EULAR Rheumatology Open Medicine
Dual targeted therapy with anakinra and Janus kinase inhibition in multidrug-refractory adult-onset still’s disease: a case report with nearly 7 years of follow-up
The publisher did not provide an abstract — full text is available via the link below.